Peiling Chen

State Key Laboratory Of Respiratory Disease
Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

First-line treatment for unresectable pulmonary lymphoepithelial carcinoma: A real-world comparison of platinum-based doublet chemotherapy with or without PD-1 inhibitors.

First-line treatment for unresectable pulmonary lymphoepithelial carcinoma: A real-world comparison of platinum-based doublet chemotherapy with or without PD-1 inhibitors.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: June 02, 2026

Lung cancer location drives lateralized ventilation loss and adverse outcome.

Lung cancer location drives lateralized ventilation loss and adverse outcome.

Journal: Respiratory medicine

Published: February 18, 2026

The 2025 lung cancer landscape: advances in screening, molecular taxonomy and therapeutic strategy: a narrative review.

The 2025 lung cancer landscape: advances in screening, molecular taxonomy and therapeutic strategy: a narrative review.

Journal: Translational lung cancer research

Published: December 22, 2025

Integrative fragmentomic and mutational signature profile of plasma cfDNA for early lung cancer detection.

Integrative fragmentomic and mutational signature profile of plasma cfDNA for early lung cancer detection.

Journal: NPJ precision oncology

Published: November 29, 2025

Treatments of depressive symptoms in cancer patients: A systematic review and network meta-analysis.

Treatments of depressive symptoms in cancer patients: A systematic review and network meta-analysis.

Journal: Translational psychiatry

Published: March 28, 2025

Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in China.

Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in China.

Journal: Translational lung cancer research

Published: March 10, 2025

DeepSeek: the "Watson" to doctors-from assistance to collaboration.

DeepSeek: the "Watson" to doctors-from assistance to collaboration.

Journal: Journal of thoracic disease

Published: February 22, 2025

Composite dietary antioxidant index and lung cancer risk: insights from the UK biobank.

Composite dietary antioxidant index and lung cancer risk: insights from the UK biobank.

Journal: BMC public health

Published: August 09, 2024

Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLC.

Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLC.

Journal: BMJ open respiratory research

Published: May 14, 2024

Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data.

Landscape of C-MET overexpression in non-small cell lung cancer: a large-scale study of clinicomolecular features and prognosis based on Chinese data.

Journal: Therapeutic advances in medical oncology

Published: March 12, 2024

Diameter thresholds for pure ground-glass pulmonary nodules at low-dose CT screening: Chinese experience.

Diameter thresholds for pure ground-glass pulmonary nodules at low-dose CT screening: Chinese experience.

Journal: Thorax

Published: March 05, 2024

Identifying genetically-supported drug repurposing targets for non-small cell lung cancer through mendelian randomization of the druggable genome.

Identifying genetically-supported drug repurposing targets for non-small cell lung cancer through mendelian randomization of the druggable genome.

Journal: Translational lung cancer research

Published: January 18, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026